Japanese encephalitis (JE) is a widespread mosquito-borne flavi virus infection that occurs in annual epidemics of potentially lethal en cephalitis in Thailand. l In northern Thailand. more than 900/0 of children have neutralization antibody by age 14; 50 % seroprevalence is found to be age-related.s In an ong('ing. pla cebo-controlled study of the efficacy of an available inactivated Japanese encephalitis vaccine (JEV AC;BIKEN), greater than 90 % protection was afforded to volunteers, aged 1-4 years. who received two 0.5 ml (age 3) o
Japanese encephalitis (JE) virus is a leading cause of encephalitis in Asia, causing an estimated 67...
Background: Genotype I (GI) Japanese encephalitis virus (JEV) that replaced GIII virus has become th...
The Japanese encephalitis virus (JEV) is endemic in many countries in southern Asia and the western ...
million children have been immunised with the SA 14-14-2 live-attenuated Japanese encephalitis (JE) ...
AbstractBackgroundJapanese encephalitis is a mosquito-borne viral disease endemic in most countries ...
brain-derived JE vaccine produced and used in Japan since 1966. Two doses of this vaccine given 1-2 ...
Japanese encephalitis (JE) is a major public health problem in Southeast Asia with around 50,000 cas...
years old (85.7 % of the target poopulation) in Dong Anh Distict, Hanoi, Vietnam, were im-munized wi...
From January 1986 to 1988, a total 27, 700 children between 3 months to 5 years old (85.7% of the ta...
Objectives: We estimate the effectiveness of Japanese encephalitis (JE) SA 14-14-2 live-attenuated v...
Background: Japanese encephalitis (JE) is the most important cause of viral encephalitis in Asia. ;M...
In Viet Nam, an inactivated, mouse brain-derived vaccine for Japanese encephalitis (JE) has been giv...
Background: Japanese encephalitis (JE) is a flaviviral disease of public health concern in many part...
A new live attenuated Japanese encephalitis chimeric virus vaccine (JE-CV) has been developed based ...
On June 19, 2013, the Advisory Committee on Immunization Practices (ACIP) voted to extend existing r...
Japanese encephalitis (JE) virus is a leading cause of encephalitis in Asia, causing an estimated 67...
Background: Genotype I (GI) Japanese encephalitis virus (JEV) that replaced GIII virus has become th...
The Japanese encephalitis virus (JEV) is endemic in many countries in southern Asia and the western ...
million children have been immunised with the SA 14-14-2 live-attenuated Japanese encephalitis (JE) ...
AbstractBackgroundJapanese encephalitis is a mosquito-borne viral disease endemic in most countries ...
brain-derived JE vaccine produced and used in Japan since 1966. Two doses of this vaccine given 1-2 ...
Japanese encephalitis (JE) is a major public health problem in Southeast Asia with around 50,000 cas...
years old (85.7 % of the target poopulation) in Dong Anh Distict, Hanoi, Vietnam, were im-munized wi...
From January 1986 to 1988, a total 27, 700 children between 3 months to 5 years old (85.7% of the ta...
Objectives: We estimate the effectiveness of Japanese encephalitis (JE) SA 14-14-2 live-attenuated v...
Background: Japanese encephalitis (JE) is the most important cause of viral encephalitis in Asia. ;M...
In Viet Nam, an inactivated, mouse brain-derived vaccine for Japanese encephalitis (JE) has been giv...
Background: Japanese encephalitis (JE) is a flaviviral disease of public health concern in many part...
A new live attenuated Japanese encephalitis chimeric virus vaccine (JE-CV) has been developed based ...
On June 19, 2013, the Advisory Committee on Immunization Practices (ACIP) voted to extend existing r...
Japanese encephalitis (JE) virus is a leading cause of encephalitis in Asia, causing an estimated 67...
Background: Genotype I (GI) Japanese encephalitis virus (JEV) that replaced GIII virus has become th...
The Japanese encephalitis virus (JEV) is endemic in many countries in southern Asia and the western ...